MedPath

Comparison between effect of two drugs on blood loss in patients undergoing abdominal myomectomy operatio

Phase 4
Conditions
Health Condition 1: D259- Leiomyoma of uterus, unspecifiedHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2024/01/061949
Lead Sponsor
Institute of Post Graduate Medical Education and Research and SSKM Hospital Kolkata
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Body weight between 50 - 90 kgs

2. Symptomatic leiomyomas and scheduled to undergo abdominal myomectomy

3. With number of myoma = 5

4. Myoma FIGO staging 3 to 6

Exclusion Criteria

1. Unwilling patient

2. Patients undergone vaginal or laparoscopic myomectomy

3. Patients received preoperative embolisation or GnRh analogue

4. Previous myomectomy

5. Pregnant and postmenopausal women

6. Myoma FIGO staging 1,2,7 & 8

7. Cervical and broad ligament myoma

8. Allergy or contraindications to Carbetocin such as coronary artery disease, asthma, epilepsy, migraine, kidney and hepatic diseases

9. Preoperative haemoglobin concentration less than 10 gm per d

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath